News archive
Showing 708 results
June 2025
-
Story Hope
3 Innovative Ways We’re Reaching Patients, Beyond Our Medicines
At Aspen Ideas Health, Novartis is leading conversations about how to address today’s most pressing healthcare concerns. Learn how we’re launching bold awareness campaigns and unique community partnerships—meeting patients where they are to drive change.
-
Story Discovery Cancer
3 Ways We're Innovating Advanced Prostate Cancer Care
-
Story Education and Awareness
How Katy, a Patient Turned Advocate, Found Her Purpose
Katy Shusta is helping to rewrite the narrative around hidradenitis suppurativa (HS) – a painful skin condition impacting as many as one in 100 people worldwide.1
-
Media Release
Novartis Pluvicto™ demonstrates statistically significant and clinically meaningful rPFS benefit in patients with PSMA-positive metastatic hormone-sensitive prostate cancer
Ad hoc announcement pursuant to Art. 53 LR At interim analysis, PSMAddition trial met its primary endpoint showing statistically significant and clinically meaningful benefit for Pluvicto™ plus… -
Media Release
Novartis Kisqali® reduces risk of recurrence in younger patients with early breast cancer in NATALEE subgroup analysis
33% reduction in relative risk of invasive disease observed in pre-menopausal early breast cancer (EBC) patients receiving Kisqali in 1-year post-treatment analysis1 Tolerability remained…
May 2025
-
Story Education and Awareness
Introducing the GARAGE by iLab: Behind the Scenes at Our New Innovation Hub
Learn about the launch of our new state-of-the-art space, built to accelerate innovation from the inside out and provide new solutions for employees, partners and ultimately, our patients.
-
Story Hope
Exploring the Future of Cancer Care at the Time100 Health Impact Dinner
What does it mean to be diagnosed – or living with – cancer today? Novartis US President Victor Bultó offers insights into the changing oncology landscape. -
Story Discovery
How We’re Reimagining Cancer Care for the Next Generation Patient
-
Story Education and Awareness
Addressing Elevated Lipoprotein(a): The Importance of Testing At-Risk Patients
Elevated Lp(a) is a unique and genetically determined condition that can increase risk for ASCVD1. Read on to learn more about patient populations at risk.
-
Media Release
New Novartis data at ASCO and EHA showcase momentum of pioneering portfolio with promising pipeline
NATALEE subanalysis evaluates Kisqali in pre-menopausal early breast cancer patients, amid rising diagnosis rates in younger patients Pluvicto analysis and Scemblix ASC4START primary… -
Story Education and Awareness
Autoimmune Diseases Disproportionately Impact Women — Here’s Why That Matters
Novartis is raising awareness about the disproportionate impact and often invisible burden of autoimmune diseases on women.